Significant mortality, morbidity and resource utilization associated with advanced heart failure in congenital heart disease in children and young adults
- 1 March 2019
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 209, 9-19
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Drug Treatment of Heart Failure in Children: Focus on Recent Recommendations from the ISHLT Guidelines for the Management of Pediatric Heart FailurePediatric Drugs, 2016
- Hospital Charges for Pediatric Heart Failure-Related Hospitalizations from 2000 to 2009Pediatric Cardiology, 2015
- Measuring Hospital Performance in Congenital Heart Surgery: Administrative Versus Clinical Registry DataThe Annals of Thoracic Surgery, 2015
- A decade of investment in infection prevention: A cost-effectiveness analysisAmerican Journal of Infection Control, 2015
- Excess Costs Associated With Complications and Prolonged Length of Stay After Congenital Heart SurgeryThe Annals of Thoracic Surgery, 2014
- Utility of a Clinical Practice Guideline in Treatment of Chylothorax in the Postoperative Congenital Heart PatientThe Annals of Thoracic Surgery, 2013
- Guideline-Concordant Therapy and Reduced Mortality and Length of Stay in Adults With Community-Acquired PneumoniaArchives of internal medicine (1960), 2009
- Corticosteroids and Mortality in Children With Bacterial MeningitisJAMA, 2008
- Carvedilol for Children and Adolescents With Heart FailureJAMA, 2007
- The effect of treatment with angiotensin-converting enzyme inhibitors on survival of pediatric patients with dilated cardiomyopathyPediatric Cardiology, 1993